Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,020 INR | -0.48% | +2.14% | +25.74% |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.74% | 220.46Cr | |
+38.74% | 73TCr | |
+33.05% | 60TCr | |
-6.07% | 36TCr | |
+18.61% | 33TCr | |
+0.96% | 28TCr | |
+16.00% | 24TCr | |
+8.09% | 21TCr | |
-5.77% | 21TCr | |
+6.19% | 16TCr |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Natco Pharma : Marketing Partner Gets Tentative Nod for Carfilzomib Vials